VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,140,000 | +68191.2% | 2,000,000 | 0.0% | 1.18% | -21.6% |
Q2 2023 | $32,420 | -2.6% | 2,000,000 | 0.0% | 1.50% | -8.1% |
Q1 2023 | $33,300 | -99.8% | 2,000,000 | +33.3% | 1.64% | +120.2% |
Q4 2022 | $14,100,000 | -60.4% | 1,500,000 | -60.0% | 0.74% | -81.6% |
Q2 2018 | $35,588,000 | +155.6% | 3,750,000 | +17.7% | 4.03% | +171.2% |
Q1 2018 | $13,923,000 | – | 3,186,000 | – | 1.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |